Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Urokinase-Type Plasminogen Activator and Genistein

Research Papers that Mention the Interaction

“ Genistein inhibited uPA secreted by F3II cell monolayers, while inducing an increase in the proteolytic activity of B16 cells.”
Oncology reports  •  2006  |  View Paper
“ Genistein exhibited a dose-dependent inhibition of expression/excretion of vascular endothelial growth factor165, platelet-derived growth factor, tissue factor, urokinase plasminogen activator , and matrix metalloprotease-2 and 9, respectively.”
Biochemical pharmacology  •  2005  |  View Paper
“The effect of urokinase was completely suppressed by genistein and by herbimycin A indicating that tyrosine kinase(s) are required for MMP9 production.”
Journal of Vascular Research  •  2006  |  View Paper
“Here we demonstrate that genistein suppresses cell adhesion and migration by inhibiting the constitutively active transcription factors NF-kappaB and AP-1, resulting in the suppression of secretion of urokinase-type plasminogen activator (uPA) in breast cancer cells MDA-MB-231.”
“However, only genistein and daidzein inhibited constitutively active NF-kappaB and AP-1 and suppressed secretion of uPA from breast cancer cells.”
International journal of oncology  •  2004  |  View Paper
“The alphavbeta6 correlated increase in HMW-uPA and pro-MMP secretion could be inhibited by tyrosine kinase inhibitor genistein or the MEK 1 inhibitor U0126, consistent with a role of active p42/44 MAPK in the elevation of uPA, MMP-9, and MMP-2 secretion.”
Journal of cellular biochemistry  •  2002  |  View Paper
“ Genistein attenuated uPA activity and stimulated PAI activity in both cell lines, leading to a decrease in the PA/PAI ratio.”
European journal of cancer  •  1998  |  View Paper
“However, genistein suppressed the growth stimulatory effect of growth factors on HCE 16/3 cells and also reduced KGF-enhanced uPA secretion in this cell line.”
Zhonghua zhong liu za zhi [Chinese journal of oncology]  •  1997  |  View Paper
“ Genistein , a specific tyrosine kinase inhibitor, reduced the constitutive and staurosporine‐induced uPA and MMP‐9 secretion.”
International journal of cancer  •  1998  |  View Paper